Abstract
Objective: Perioperative red blood cell transfusion (PRBCT) has been implicated as a negative prognostic marker in surgical oncology. The impact of PRBCT on outcomes in epithelial ovarian cancer (EOC) has not been previously reported. We assessed whether PRBCT is an independent risk factor for recurrence and death from EOC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
